FDA Clearance Tracker · P070001
PRODISC TM-C TOTAL DISC REPLACEMENT
Last checked: Nov 20, 2026Latest source record: Dec 17, 2007 (this decision)Source: openFDAMethods & limitations
Decided
Dec 17, 2007
Approved
Time to decision
348 days
Received Jan 3, 2007. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P070001
- Device name
- PRODISC TM-C TOTAL DISC REPLACEMENT
- Applicant
- Centinel Spine, LLC
- Applicant location
- West Chester, PA
- Received
- Jan 3, 2007
- Decided
- Dec 17, 2007
- Decision
- Approved
- Supplements
- 27 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Prosthesis, intervertebral disc (MJO)
- Device class
- Class III
- Specialty
- Orthopedic SurgerySpine
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE PRODISC-C TOTAL DISC REPLACEMENT. THE DEVICE IS INDICATED FOR SKELETALLY MATURE PATIENTS FOR RECONSTRUCTION OF THE DISC FROM C3-C7 FOLLOWING SINGLE-LEVEL DISCECTOMY FOR INTRACTABLE SYMPTOMATIC CERVICAL DISC DISEASE (SCDD). SYMPTOMATIC CERVICAL DISC DISEASE IS DEFINED AS NECK OR ARM (RADICULAR) PAIN AND/OR A FUNCTIONAL/NEUROLOGICAL DEFICIT WITH AT LEAST ONE OF THE FOLLOWING CONDITIONS CONFIRMED BY IMAGING (CT, MRI, OR X-RAYS): HERNIATED NUCLEUS PULPOSUS, SPONDYLOSIS (DEFINED BY THE PRESENCE OF OSTEOPHYTES), AND/OR LOSS OF DISC HEIGHT. THE PRODISC-C TOTAL DISC REPLACEMENT IS IMPLANTED VIA AN OPEN ANTERIOR APPROACH. PATIENTS RECEIVING THE PRODISC-C TOTAL DISC REPLACEMENT SHOULD HAVE FAILED AT LEAST SIX WEEKS OF NON-OPERATIVE TREATMENT PRIOR TO IMPLANTATION OF THE PRODISC-C TOTAL DISC REPLACEMENT.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MJO. The earliest in FDA's data is P040006, decided Oct 26, 2004.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Centinel Spine, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263159 · Decided Oct 7, 2026 · 28 days after receipt
Device type: Manual Instruments Designed For Use With Total Disc Replacement Devices (QLQ) · Orthopedic Surgery
- prodisc C SK and prodisc C VivoPMA supplement
P070001-S025 · Decided Oct 10, 2025 · 744 days after receipt · Panel Track
Device type: Prosthesis, intervertebral disc (MJO) · Orthopedic Surgery
- prodisc® L Instruments510(k)
K250554 · Decided Apr 25, 2025 · 59 days after receipt
Device type: Manual Instruments Designed For Use With Total Disc Replacement Devices (QLQ) · Orthopedic Surgery
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.